Package-Ref? HRD Cocktail Reference Standard
CBP90023
詢 價
索取COA
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| Introduction | ||||||||
| 專利 | 該產(chǎn)品開發(fā)基于我們<<一種用于DNA同源重組修復(fù)基因檢測的標準品及其制備方法>>專利轉(zhuǎn)化 | |||||||
| Format | Genomic DNA | |||||||
| Description | In terms of mechanism of action, tumor cells with HRD are more sensitive to platinum drugs or PARP inhibitors. In ovarian cancer, BRCA gene mutation, HRR gene mutation, gene promoter methylation, and other reasons can all cause HRD. HRD testing may provide opportunities for benefit for BRCA-negative patients. HRD positive is a reasonable biomarker for choosing maintenance therapy with PARP inhibitors. | |||||||
| Catalog ID | Sample | 匹配度 | HRD Score | 藥敏 | HRR | 備注 | COA下載 | |
| CBP90023-1 | HRD-P1 | 0.86 | Positive -High | 78.4 | 500x WES分享 | 配對樣本 | 請點擊下載 | |
| CBP90023-2 | HRD-P2 | 0.84 | Positive -High | 33.73 | 500x WES分享 | 配對樣本 | 請點擊下載 | |
| CBP90023-9 | HRD-P9 | 0.9 | Positive-High | N/A | 500x WES分享 | 配對樣本 | 請點擊下載 | |
| CBP90023-3 | HRD-P3 | 0.8 | Positive-High | 144.54 | 500x WES分享 | 配對樣本 | 請點擊下載 | |
| CBP90023-4 | HRD-P4 | 0.83 | Critical Value-Median | 67.9 | 500x WES分享 | 配對樣本 | 請點擊下載 | |
| CBP90023-15 | HRD-P15 | 0.88 | Critical Value-Median | N/A | 500x WES分享 | 配對樣本 | 請點擊下載 | |
| CBP90023-10 | HRD-P10 | 0.92 | Negative-Low | 100 | 500x WES分享 | 配對樣本 | 請點擊下載 | |
| CBP90023-13 | HRD-P13 | 0.95 | Negative-Low | 2.14 | 500x WES分享 | 配對樣本 | 請點擊下載 | |
| Product Information | ||||||||
| Intended Use | Research Use Only | |||||||
| Unit Size | 1ug/vial * 2 vial | |||||||
| Concentration | Download for COA | |||||||
| Purity | Download for COA | |||||||
| DNA electrophoresis | Download for COA | |||||||
| Storage | 2-8℃ | |||||||
| Expiry | 36 months from the date of manufacture | |||||||
